ECS Exclusive: How we pulled off the biggest cross-border pot deal in Aussie history

ECS Exclusive: How we pulled off the biggest cross-border pot deal in Aussie history

On Tuesday, northern Victorian quiet achiever – the medicinal cannabis cultivator and manufacturer ECS Botanics (ASX:ECS) – revealed it secured a stunning five-year, $24 million deal to supply Perth-based MediCann Health with its top (medicinal cannabis dried flower) strain. The deal builds on the existing two-year contract and expects to deliver over four tonnes of dried cannabis flower…

ECS Botanics (ASX:ECS) secures $9.9m cannabis supply agreement

ECS Botanics (ASX:ECS) secures $9.9m cannabis supply agreement

ECS Botanics (ECS) has secured a $9.9 million supply agreement for medicinal cannabis products in Germany. The company entered a binding agreement with German company Ilios Santé GmbH for the supply of medicinal cannabis. Under the contract, ECS will exclusively supply four medicinal cannabis strains to Ilios Sante, with the first supply anticipated once product…

ECS Botanics (ASX:ECS) secures $11.9m to supply medicinal cannabis dried flower in Australia

ECS Botanics (ASX:ECS) secures $11.9m to supply medicinal cannabis dried flower in Australia

ECS Botanics (ECS) has entered two offtake agreements worth a combined more than $11.9 million to supply medicinal cannabis dried flower in Australia. The company announced it will supply Melbourne-based Entoura with Good Manufacturing Practice (GMP) medicinal cannabis dried flower, worth $10.2 million over three years. Entoura supplies and develops high-quality medicinal cannabis products, but also…

ECS Botanics (ASX:ECS) frees up funds with asset sales and new debt facility

ECS Botanics (ASX:ECS) frees up funds with asset sales and new debt facility

Medicinal cannabis company, ECS Botanics (ECS) has launched the sale of two assets and secured a new loan facility. The company agreed to sell its hemp food and wellness business for $250,000 to Ananda Food, with contract completion expected in August upon the finalisation of due diligence. In addition, the company has planned to sell its…

ECS Botanics (ASX:ECS) hands over Tasmanian assets to Blue Buffalo

ECS Botanics (ASX:ECS) hands over Tasmanian assets to Blue Buffalo

ECS Botanics (ECS) has reached financial settlement of its Tasmanian medicinal cannabis business and assets for $3 million. The medicinal cannabis company agreed to sell its subsidiary, TasCo, which holds its Tasmanian operations and farm, to Blue Buffalo for $3 million. On October 24, the company announced to the market it had entered an unconditional…

Medicinal cannabis grower ECS Botanics locks in $24m supply deal with MediCann Health

Medicinal cannabis grower ECS Botanics locks in $24m supply deal with MediCann Health

Shares in ECS Botanics (ASX: ECS) rose by more than 22 per cent this morning after the Victorian medicinal cannabis grower and manufacturer announced its third supply contract win in just over three months, taking the total value of agreements reached since late June to $35.9 million.

Australian Cannabis Companies – top 20
|

Australian Cannabis Companies – top 20

Australian Cannabis Companies 2022 – top 20 list Whether it’s a “gold rush” to secure registration for selling over-the-counter at chemists, proactive outreach to get clinicians on side, or pocket-emptying, long-game research requiring patience and patients at a pharmaceutical level, medicinal cannabis is an industry that attracts all stripes. Against the backdrop of a global…

ECS delivers 450% PCP growth in Q3 revenue, targets UK and European giants as new frontiers for its homegrown cannabis

ECS delivers 450% PCP growth in Q3 revenue, targets UK and European giants as new frontiers for its homegrown cannabis

ECS Botanics has had another incredibly productive quarter, producing revenue of over $2m in Q3. And with the European majors opening up, the vertically integrated company says it’s in a great position with harvesting currently underway. Benchmark Aussie medicinal cannabis play ECS Botanics (ASX:ECS) has delivered more than $2million in revenue for the third quarter, as demand…

‘Our first cannabis crops failed, but we learned along the way’

‘Our first cannabis crops failed, but we learned along the way’

Having a regulatory compliance expert for a husband may have kick-started her cannabis career, but Nan-Maree Schoerie is ploughing her own path in the industry. In the first of a two-part interview with Cannabiz, she tells of the early days of Murray Meds and explains why greenhouse growing is no longer sustainable in Australia. Sometimes in…

ECS Botanics inks cannabis supply and tolling deal with Sun Pharma
|

ECS Botanics inks cannabis supply and tolling deal with Sun Pharma

Medicinal cannabis and hemp company ECS Botanics Holdings (ASX: ECS) has revealed it has entered into a collaborative supply and toll processing agreement for cannabis biomass extraction with pharmaceutical company Sun Pharma. Sun Pharma is an Australia-based subsidiary of Sun Pharmaceutical Industries, the fourth largest specialty generic pharmaceutical company in the world. With global revenues in excess…

Germany: Likely future government supports cannabis legalisation

Germany: Likely future government supports cannabis legalisation

The country’s next coalition government plans to keep cannabis tightly regulated, party representatives said. Recreational use of cannabis is only legal in two other EU countries. Germany’s future coalition of the Social Democrats (SPD), Green party, and Free Democrats (FDP), have signalled that they are seriously considering legalizing the possession of cannabis. Representatives from the parties told…

Alex Keach “I GREW UP WITH POPPY FIELDS ALL AROUND ME. SO, WHY NOT CANNABIS?”

Alex Keach “I GREW UP WITH POPPY FIELDS ALL AROUND ME. SO, WHY NOT CANNABIS?”

Australian cannabis companies are standing out as making a cautious yet steady entry into the cannabis industry. One of these companies is ECS Botanics. “ECS Botanics started as a hemp company,” says Alex Keach, founder, and Managing Director of ECS Botanics. “We have a farm in Tasmania where we grow our cannabis outdoors.” The idea…

Cannabidiol: The ultimate investor’s guide to a potential $64 billion global market

Cannabidiol: The ultimate investor’s guide to a potential $64 billion global market

Cannabis has been used as medicine for thousands of years. Ancient Indian, Chinese, and Egyptian civilisations have all employed it to cure various illnesses. But increasing recreational use and perceived harm to society meant that it has been outlawed in many countries since the early 20th century. In the US for example, cannabis was restricted…

Canngea attracted to ECS Botanics’ sustainably grown cannabis, inks deal

Canngea attracted to ECS Botanics’ sustainably grown cannabis, inks deal

The company flagged additional revenue opportunities in the year ahead as it establishes traction as the leading B2B supplier in the Australian cannabis market as the supply agreement with Canngea finalised. Leading medicinal cannabis company ECS Botanics (ASX:ECS) continues to execute on a rapid growth trajectory, as it gains traction as the supplier of choice for a…

ECS Botanics Managing Director Message: Why Australia for Medicinal Cannabis

ECS Botanics Managing Director Message: Why Australia for Medicinal Cannabis

Dear shareholders, FY21 has been a defining year for the company as we start to leverage assets that we have established in proceeding years. These include our production base, industry leading team and culture, intellectual property and systems. As a result, the company is at a major inflection point. We are now in a position…

Lean, mean and green: ECS Botanics, holds medicinal cannabis licenses and GMP standards to execute on a global market opportunity

Lean, mean and green: ECS Botanics, holds medicinal cannabis licenses and GMP standards to execute on a global market opportunity

Managing Director, Alex Keach breaks down the demand dynamics for medicinal cannabis & GMP complaint products, as ECS Botanics Holdings looks to execute on a global market opportunity. After a multi-year period of development, the pieces are now in place for Australia to become a global leader in the production, sale and export of medicinal cannabis, ECS Botanics’ Managing…